1. Home
  2. CCCC vs IMMR Comparison

CCCC vs IMMR Comparison

Compare CCCC & IMMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • IMMR
  • Stock Information
  • Founded
  • CCCC 2015
  • IMMR 1993
  • Country
  • CCCC United States
  • IMMR United States
  • Employees
  • CCCC N/A
  • IMMR N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • IMMR Computer peripheral equipment
  • Sector
  • CCCC Health Care
  • IMMR Technology
  • Exchange
  • CCCC Nasdaq
  • IMMR Nasdaq
  • Market Cap
  • CCCC 423.8M
  • IMMR 310.3M
  • IPO Year
  • CCCC 2020
  • IMMR 1999
  • Fundamental
  • Price
  • CCCC $6.48
  • IMMR $13.33
  • Analyst Decision
  • CCCC Buy
  • IMMR Strong Buy
  • Analyst Count
  • CCCC 7
  • IMMR 1
  • Target Price
  • CCCC $8.71
  • IMMR $11.00
  • AVG Volume (30 Days)
  • CCCC 2.1M
  • IMMR 778.8K
  • Earning Date
  • CCCC 08-06-2024
  • IMMR 08-09-2024
  • Dividend Yield
  • CCCC N/A
  • IMMR 1.39%
  • EPS Growth
  • CCCC N/A
  • IMMR 33.01
  • EPS
  • CCCC N/A
  • IMMR 1.37
  • Revenue
  • CCCC $20,036,000.00
  • IMMR $70,692,000.00
  • Revenue This Year
  • CCCC $26.24
  • IMMR $107.91
  • Revenue Next Year
  • CCCC N/A
  • IMMR N/A
  • P/E Ratio
  • CCCC N/A
  • IMMR $9.60
  • Revenue Growth
  • CCCC N/A
  • IMMR 84.93
  • 52 Week Low
  • CCCC $1.06
  • IMMR $5.94
  • 52 Week High
  • CCCC $11.88
  • IMMR $13.59
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 62.05
  • IMMR 83.01
  • Support Level
  • CCCC $5.81
  • IMMR $11.58
  • Resistance Level
  • CCCC $7.66
  • IMMR $13.32
  • Average True Range (ATR)
  • CCCC 0.57
  • IMMR 0.52
  • MACD
  • CCCC 0.15
  • IMMR 0.25
  • Stochastic Oscillator
  • CCCC 64.30
  • IMMR 90.26

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.

About IMMR Immersion Corporation

Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.

Share on Social Networks: